This text of New Mexico § 59A-59A-4 (Pharmacy services administrative organization) is published on Counsel Stack Legal Research, covering New Mexico primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
reporting requirements. A. By June 30, 2025, and annually thereafter, except as provided by Subsection B of this section, each pharmacy services administrative organization that represents a pharmacy or chain of pharmacies that do business in this state shall submit data to the superintendent, in a form and manner prescribed by the superintendent, that includes a list of the:
(1)negotiated reimbursement rate of the twenty-five prescription drug products with the highest reimbursement rate;
(2)twenty-five prescription drug products with the highest year-to-year percentage change in reimbursement rate;
(3)twenty-five prescription drug products with the highest year-to-year change in reimbursement rate based on the total dollar amount of change; and (4) schedule of fees charged to pharmaci
Free access — add to your briefcase to read the full text and ask questions with AI
reporting requirements. A. By June 30, 2025, and annually thereafter, except as provided by Subsection B of this section, each pharmacy services administrative organization that represents a pharmacy or chain of pharmacies that do business in this state shall submit data to the superintendent, in a form and manner prescribed by the superintendent, that includes a list of the: (1) negotiated reimbursement rate of the twenty-five prescription drug products with the highest reimbursement rate; (2) twenty-five prescription drug products with the highest year-to-year percentage change in reimbursement rate; (3) twenty-five prescription drug products with the highest year-to-year change in reimbursement rate based on the total dollar amount of change; and (4) schedule of fees charged to pharmacies for the services provided by the pharmacy services administrative organization. B. A pharmacy services administrative organization that solely generates revenue from charging flat service fees to pharmacies and does not charge pharmacies for services based on prescription drug product prices or volume shall be exempt from the reporting requirements of this section. C. Except for the superintendent's reporting requirements in Section 7 [59A-59A-7 NMSA 1978] of the Prescription Drug Price Transparency Act, the superintendent and a person acting on behalf of the superintendent, including staff and third-party contractors, shall keep confidential all of the information provided pursuant to this section, and the information shall not be subject to the requirements of the Inspection of Public Records Act [Chapter 14, Article 2 NMSA 1978]. The superintendent shall include in every contract for services related to the Prescription Drug Price Transparency Act a requirement that contractors and subcontractors do not disclose confidential information to any persons other than the superintendent or a person acting on behalf of the superintendent.